Big Data in Transfusion Medicine and Artificial Intelligence Analysis for Red Blood Cell Quality Control
Marcelle G. M. Lopes, Steffen M. Recktenwald, Greta Simionato, Hermann Eichler, Christian Wagner, Stephan Quint, Lars Kaestner
Saarland University Institute for Transfusion Medicine University of Luxembourg
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Background: "Artificial intelligence" and "big data" increasingly take the step from just being interesting concepts to being relevant or even part of our lives. This general statement holds also true for transfusion medicine. Besides all advancements in transfusion medicine, there is not yet an established red blood cell quality measure, which is generally applied. Summary: We highlight the usefulness of big data in transfusion medicine. Furthermore, we emphasize in the example of quality control of red blood cell units the application of artificial intelligence. Key Messages: A variety of concepts making use of big data and artificial intelligence are readily available but still await to be implemented into any clinical routine. For the quality control of red blood cell units, clinical validation is still required.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Blood transfusion and management
Erythropoietin and Anemia Treatment · Blood groups and transfusion
参考文献 99
此处列出前 3 条
引用本文 39
按被引量排序,此处列出前 3 条